• EQT Private Equity and Goldman Sachs to acquire Parexel expresspharma
    July 05, 2021
    Parexel, a global clinical research organisation (CRO), announced the execution of a definitive merger agreement under which it will be acquired by EQT IX fund (EQT Private Equity) and the private equity business within Goldman Sachs Asset Management ...
PharmaSources Customer Service